跳至主要内容
临床试验/NCT01573364
NCT01573364已完成不适用

Evaluation of the Prevalence and the Reversibility of the Lung Hyperinflation in Uncontrolled Persistent Asthmatic Patients With Dyspnea

Chiesi Farmaceutici S.p.A.1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
450
试验地点
1

研究概览

简要总结

The aim of this observational study is to evaluate the pulmonary hyperinflation and its immediate reversibility to a short acting beta2 agonist test in uncontrolled persistent asthmatic patients with dyspnea.

详细描述

The other objectives are :

  • the evaluation of the hyperinflation defined by an increase of the residual volume (RV),
  • the observation of the relationship between the hyperinflation and the asthma characteristics,
  • the study of the improvement of the functional parameters after a reversibility test
  • the evaluation of the correlation between hyperinflation parameters evolution, chest tightness and dyspnea

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with a diagnosis of uncontrolled persistent asthma (ACT </= 19) or with an MRC score of dyspnea >/= 1
  • Patient requiring a check-up including a pulmonary function test by plethysmography with a reversibility test

排除标准

  • Patient participating to an other clinical trial or having participated to a clinical trial with medicine in the last 3 months

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验